| | Does Treatment With Calciferol Have a Role in CKD Patients?VITAMIN D, THE “sunshine vitamin”, has received a great deal of attention because of its widespread deficiency in the general population and correlations between low vitamin D levels and increased risks for autoimmune disorders, heart disease, and certain cancers. The amount of vitamin D needed to prevent deficiencies remains unclear, and as does the question of how much is too much. This product update will briefly review vitamin D metabolism and sources of vitamin D, and address low vitamin D levels in the chronic kidney disease (CKD) population. Vitamin D Metabolism  “Vitamin D” refers to a group of fat-soluble prohormones. Vitamin D is produced endogenously in the skin, and is available in certain foods (either naturally or through fortification) or as a dietary supplement. Plant sources of vitamin D are in the form of ergocalciferol (D2), whereas animal sources are in the form of cholecalciferol (D3). Collectively, D2 and D3 are known as calciferol. Regardless of whether or not you receive vitamin D from food, dietary supplements, or the sun, these forms of vitamin D are inactive and require two hydroxylations. The first step occurs in the liver, to form 25 OHD (calcidiol), and the final step occurs with the addition of 1-α hydroxylase in the kidneys, to make 1,25 OHD or calcitriol, a potent hormone and the active form of vitamin D.1 Calcitriol produced from the kidneys is then released into circulation and has a systemic effect. Researchers have known for years the benefits of vitamin D, its role in bone mineral homeostasis, and the presence of vitamin D receptors throughout the body. The kidney was once believed to be the only location of 1-α hydroxylase activity. However, researchers are discovering that multiple tissues, including the colon, breast, prostate, and bone marrow, have 1-α hydroxylase enzymes that can convert circulating 25 OHD to active 1,25 OHD.2 Rather than exerting a systemic effect, calcitriol produced at the cellular level has more of a physiologic autocrine and paracrine function, acting through the vitamin D receptors of a particular cell.1, 2, 3, 4 This likely explains the correlation between low vitamin D levels and the risk for developing colon, breast, and other cancers. Although recent studies indicate vitamin D deficiency in the general population, we have known for years that CKD patients are vitamin D-deficient. Calcitriol levels decrease as renal function declines, and after our patients reach CKD stage 5 (estimated glomerulofiltration rate<15 mL/min), most are unable to make that final conversion of 25 OHD to 1,25 OHD.3 In dialysis, we primarily use parathyroid hormone (PTH) levels to initiate vitamin D analogs such as Hectorol or Zemplar. Wolf et al. studied a group of 825 incident hemodialysis patients, and found that 78% were vitamin D-deficient (<30 ng/mL).5 Of the study sample, women, blacks, and patients with diabetes were more likely to be vitamin D-deficient. Vitamin D deficiency correlated poorly with calcium, phosphorus, and PTH levels. In fact, nearly 80% of the patients with PTH levels <150 pg/mL were vitamin D-deficient.5 These researchers also showed a correlation between low 25 OHD levels and an increased risk of mortality within 90 days of initiating dialysis.5 Until recently, many would have argued that little benefit accrued from giving D2 or D3 if patients were unable to covert them to calcitriol. However, as we learn more about the role of vitamin D at the cellular level and the possibility of providing some protection against certain cancers, heart disease, and autoimmune diseases, we may need to rethink this assumption.2, 6 As we look to supplementing vitamin D in the general population, we should consider the risks and benefits of supplementing vitamin D in the dialysis population. One concern involves the risk of increasing serum calcium and phosphorus levels when supplementing with D2 or D3. However, several studies that examined supplementing hemodialysis patients with either D2 or D3 showed improvements in vitamin D levels from baseline, with little to no effect on serum calcium and phosphorus.4, 7 Sources of Vitamin D  Sources of vitamin D include sunlight, food sources, and dietary supplements. It is produced endogenously from 7-dehydrocholesterol when sunlight hits our skin. Although as few as 10 to 15 minutes/day of sunlight are needed to prevent deficiencies, multiple factors may interfere with getting the full benefit of the sun, including the widespread use of sunscreen, the time of day, the time of year, the latitude in which you live, angle of the sun, skin pigmentation, and age. Table 1 lists food sources of vitamin D. It is often difficult to acquire enough vitamin D from food sources, which is a contributing factor to the widespread deficiency seen in the United States. For CKD patients, many of these foods may not be readily accessible or may be too high in phosphorus to allow them to reach an intake of 1000 IU daily. Dietary supplements can provide a safe and cost-effective source of vitamin D. Table 2 list common vitamin D supplements. The type of vitamin D (D2 or D3) and how much is adequate remain unclear, both in the general population and CKD population. The vast majority of dietary supplements contain D3, which appears to be more shelf-stable and more effective at raising vitamin D levels.8, 11 | | |  | Food | Amount | Vitamin D Content | Phosphorus Content |  |
|---|
 | Bluefish | 3 ounces | 415 IU | 247 mg |  |  | Catfish | 3 ounces | 425 IU | 208 mg |  |  | Cod liver oil | 1 teaspoon | 450 IU | 0 mg |  |  | Egg yolk | 1 whole | 25 IU | 66 mg |  |  | Mackerel | 3 ounces | 395 IU | 236 mg |  |  | Milk, vitamin D-fortified | 1 cup | 100 IU | 248 mg |  |  | Mushrooms, shitake | 4 mushrooms | 55 IU | 22 mg |  |  | Oysters | 3 ounces | 545 IU | 79 mg |  |  | Salmon, farmed | 3 ounces | 275 IU | 218 mg |  |  | Salmon, wild | 3 ounces | 1000 IU | 274 mg |  |  | Sardines, canned in oil | 1.75 ounces | 230 IU | 209 mg |  |  | Shrimp | 3 ounces | 120 IU | 174 mg |  |  | Tuna, blue-fin | 3 ounces | 170 IU | 216 mg |  |  | Tuna, canned in water | 3 ounces | 135 IU | 139 mg |  | | | |
| | |  | Product | Description | Vitamin/Serving | Elemental Calcium | Phosphorus | Cost/quantity | Contact Information |  |
|---|
 | Drisdol | By prescription; vitamin D (weekly or monthly dosing) | 50,000 IU D2/soft gel | None | None | Medicaid-reimbursed in many states; out-of-pocket cost, $3 to $4/soft gel | Sanofi-Aventis U.S., LLC, Bridgewater, NJ 08807 |  |  | Caltrate | Calcium and vitamin D supplement | 400 IU D3/tablet | 240 mg | Unknown | $12.99/120 tablets | Wyeth Consumer Healthcare, P.O. Box 26609, Richmond, VA 23261-6609 |  |  | Carlson | Vitamin D supplement | 2000 IU D3/soft gel | none | none | $8.80/120 soft gels | Carlson Laboratories, 15 College Dr., Arlington Heights, IL 60004-1985; website: www.vitacost.com |  |  | CVS vitamin D | Vitamin D supplement | 1000 IU D3/tablet | 60 mg | Unknown; contains dicalcium phosphate | $5.49/100 tablets | Telephone: 888-607-4287; e-mail: customercare@cvs.com |  |  | GNC | Vitamin D | 400 IU D3/tablet | None | Unknown; contains dicalcium phosphate | $3 to $4/120 tablets | Website: www.GNC.com |  |  | Life Fitness | Vitamin D | 1000 IU D3/tablet | 60 mg | Unknown; contains dicalcium phosphate | $6.99/100 tablets | Life Fitness, 5100 N. River Road, Schiller Park, IL 60176 |  |  | Little Critters Calcium Gummy With D | Calcium and vitamin D supplement | 200 IU D2/two gummy bears | 76 mg | 100 mg tricalcium phosphate | $5.44/60 gummy bears | Northwest Natural Products; telephone: 1-800-661-2736 |  |  | Little Critters Vitamin D | Vitamin D | 800 IU D2/two gummy bears | None | None | $5.49/60 gummy bears | Northwest Natural Products; telephone: 1-800-661-2736 |  |  | Maximum D3 | Vitamin D (weekly dosing) | 10,000 IU D3/gel cap | None | None | 5 gel caps (5 weeks) = $6.40 + $4.90 shipping and handling | BTR Group, Inc., P.O. Box 501, Pittsfield, IL 62363-0501; telephone: 217-320-1597 |  |  | Nature's Bounty | Vitamin D | 400 IU D3/tablet | None | Unknown; contains dicalcium phosphate | $4.99/100 tablets | Nature's Bounty Consumer Affairs, 110 Orville Drive, Bohemia, NY 11716; telephone: 1-800-433-2990 |  |  | Nature Made | Vitamin D | 1000 IU D3/tablet | Unknown; contains calcium carbonate | None | $9.69/100 tablets | Nature Made, P.O. Box 9606, Mission Hills, CA 91346-9606; telephone: 1-800-276-2878 |  |  | Nature Made Calcium With D | Calcium and vitamin D | 200 IU D3/tablet | 200 mg | None | $8.29/130 tablets | Nature Made, P.O. Box 9606, Mission Hills, CA 91346-9606; telephone: 1-800-276-2878 |  |  | Nature's Plus | Vitamin D | 1000 IU D3/soft gel | None | None | $9.29/180 soft gels | Telephone: 1-800-645-9500 |  |  | Oscal 500 + D | Calcium and vitamin D supplement | 400 IU D3/caplet | 200 mg | None | $15.99/120 caplets | Telephone: 1-800-245-1040 |  |  | Puritan's Pride | Vitamin D3 with calcium | 1000 IU D3/tablet | 48 mg | Unknown; contains dicalcium phosphate | $5.99/100 tablets | Puritan's Pride, 1233 Montauk Highway, P.O. Box 9001, Oakdale, NY 11769-9001; website: www.purtitan.com |  |  | Vital D Rx | Renal vitamin (B complex with D3) | 1750 IU cholecalciferol | None | None | Medicaid-reimbursable in some states; out-of-pocket cost, $11 to $14/month | Nephro-Tech, Inc., Shawnee, KS 66203; telephone: 1-800-879-4755 |  |  | Vitamin Shoppe | D3 | 1000 IU D3 | None | None | $7.99/200 soft gels | Customer Care Department, The Vitamin Shoppe, 2101 91st Street, North Bergen, NJ 07047 |  |  | Vitamin World Calcium and D | Calcium and Vitamin D | 250 IU/two caplets | 480 mg | None | $7.99/250 caplets | VitaminWorld.com, 105 Orville Drive, Bohemia, NY 11716-2599; telephone: 1-866-667-8977 |  | | | |
Evaluating Vitamin D Levels  When assessing vitamin D levels, 25 OHD (calcidiol) is the best marker for concentrations of vitamin D status.1 Its concentration in the serum is about 1000-fold higher than that of calcitriol, and it has a much longer half-life of 15 days, compared with only 15 hours for calcitriol.2, 5 Although the vast majority of dialysis patients are vitamin D-deficient, it remains unclear as to which patients should have their Vitamin D levels tested and whether they should be treated if levels are low. Target groups to consider evaluating are those patients with other co-morbidities such as cancer or autoimmune disorders or those who may not have been treated with Vitamin D analogs. Also unclear is the optimal level of vitamin D for overall health and well-being, as well as the level that might be considered toxic. Severe deficiency is defined as levels <25 nmol/L, while optimal levels are set at >75 nmol/L; levels >250 nmol/L are considered toxic.1, 6, 9, 10 Addressing Low Vitamin D Levels  In the general population, adequate intake levels are recommendations by the United States Institute of Medicine of the National Academy of Sciences, in an effort to prevent deficiencies. According to current research, the recommendation of 400 to 600 IU per day appears insufficient to prevent deficiencies in many people, and for those who are vitamin D-deficient, 400 IU of vitamin D will not be enough to raise 25 OHD levels to >75 to 80 nmol/L.6 If vitamin D levels are reported low, most practitioners treat with 50,000 IU of vitamin D once a week for 6 to 12 weeks. This amount may vary, based on degree of deficiency and the physician's protocol. After the initial or loading course is completed, levels need to be rechecked. After optimal levels are achieved, they can be maintained through diet and a vitamin D supplement. Maintenance vitamin D supplementation can be given as daily dosing or monthly dosing. Because further research has shown the benefits of vitamin D, researchers are asking for increased recommendations for vitamin D of at least 1000 IU daily.2, 9 Up to 10,000 IU daily was shown to constitute a safe upper limit in the general population.2, 6 More research needs to be performed regarding safe levels in the CKD population. Conclusions  Patients with CKD are low in vitamin D, especially as they approach CKD stage 5D. We have been using vitamin D analogs to treat secondary hyperparathyroidism for years, and there appears to be a role for supplementing 25 OHD in our CKD population. With limited exposure to sunlight, and food sources that are high in phosphorus, dietary supplements are the best bet for ensuring an adequate intake of vitamin D. If you choose to recommend a vitamin D supplement, be aware that many come as vitamin D alone, some are added to multivitamins, and some are supplemented with calcium. Read the labels carefully, in an effort to make the best choice for your patient. References  1. 1National Institutes of Health: NIH Dietary Supplement Fact Sheet: Vitamin D. Available at: http://ods.od.nih.gov/factsheets/vitamind.asp#h1. 2. 2Garland CF, Garland FC, Gorham ED, et al. The role of vitamin D and cancer prevention. Am J Public Health. 2006;96:252–261. MEDLINE |
CrossRef
3. 3Medscape Survival Impact of Vitamin D Therapy in Hemodialysis Patients. Available at: http://cme.medscape.com/viewarticle/576843. 4. 4Medscape Vitamin D in Chronic Kidney Disease Prior to Dialysis: The Likely Good Outweighs the Potential Bad. Available at: http://cme.medscape.com/viewarticle/584913. 5. 5Wolf M, Shah A, Gutierizz O, Ankers E, et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2007;72:1004–1012.
CrossRef
6. 6Vieth R, Bischoff-Ferrari H, Boucher BJ, et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr. 2007;85:649–650. MEDLINE 7. 7Saab G, Young DO, Gincherman Y, Giles K, Norwood K, Coyne DW. Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients. Nephron Clin Pract. 2007;105:c132–c138. 8. 8Trang HM, Cole DEC, Rubin DEC, Pierratos A, Siu S, Vieth R. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr. 1998;68:854–858. 9. 9Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr. 2005;135:317–323. MEDLINE 10. 10Vieth R. Vitamin D supplementation, 25 hydroxyvitamin D concentrations and safety. Am J Clin Nutr. 1999;69:842–856. MEDLINE 11. 11Houghton LA, Vieth R. The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr. 2006;84:694–697. MEDLINE 12. 12United States Department of Agriculture: USDA National Nutrient Database. Available at: http://www.nal.usda.gov/fnic/foodcomp/search. Amherst Dialysis Facility, University of Virginia, Amherst, Virginia Address reprint requests to Christine Gries, MS, RD, CSR, Amherst Dialysis Facility, University of Virginia, Amherst, VA 24521.
PII: S1051-2276(09)00172-1 doi:10.1053/j.jrn.2009.07.001 © 2009 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved. | 
17 of 17
|
| |
|